CVS Health Enterprise Value Trend

CVS -- USA Stock  

USD 64.06  0.63  0.99%

This module enables investors to look at CVS Health various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Direct Expenses of 130.6 B, Consolidated Income of 934 M or Cost of Revenue of 40 B, but also many exotic indicators such as Interest Coverage of 7.166, Long Term Debt to Equity of 0.8489 or Calculated Tax Rate of 94.8315. This module is a perfect complement to use when analyzing CVS Health Valuation or Volatility. It can also complement various CVS Health Technical models. Check also analysis of CVS Health Correlation with competitors.

CVS Health Enterprise Value Marginal Breakdown

Showing smoothed Enterprise Value of CVS Health Corporation with missing and latest data points interpolated. Enterprise Value (or EV) is usually referred to as CVS Health theoretical takeover price. In the event of an acquisition, an acquirer would have to take on CVS Health debt, but would also pocket its cash. Enterprise Value is more accurate representation of CVS Health value than its market capitalization because it takes into account all of CVS Health Corporation existing debt. Enterprise value is a measure of the value of a business as a whole; calculated as [MarketCap] plus [DebtUSD] minus [CashnEqUSD].
View

166.73B

          10 Years Trend
Increasing
Stable
 Enterprise Value 
      Timeline 

CVS Health Regression Statistics

Arithmetic Mean 40,103,540,567
Geometric Mean 29,926,855,575
Coefficient Of Variation 109.96
Mean Deviation 29,095,605,765
Median 22,311,504,540
Standard Deviation 44,097,894,960
Range 144,418,495,460
R Value 0.26
R Squared 0.07
Significance 0.42
Slope 3,131,442,861

CVS Health Enterprise Value Over Time

2009  22,311,504,540 
2018  25,658,230,221 
2019  166,730,000,000 

Other Fundumenentals of CVS Health

Search macroaxis.com